Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
ANZ Journal of Surgery|December 15, 2020
Surgeon case volume and continence recovery following radical prostatectomy: a systematic reviewDanny Trieu, Irene E Ju, Simon B Chang, et al.Sexual Medicine Reviews|July 5, 2021
Surgeon Experience and Erectile Function After Radical Prostatectomy: A Systematic ReviewIrene E Ju, Danny Trieu, Simon B Chang, et al.Antimicrobial Agents and Chemotherapy|January 14, 2015
Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitorsDebananda Das, Kenji Maeda, Yasuhiro Hayashi, et al.Global Health & Medicine|December 17, 2020
A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistanceManabu Aoki, Simon B Chang, Debananda Das, et al.Scientific Reports|March 20, 2019
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1sHirotomo Nakata, Kenji Maeda, Debananda Das, et al.Antimicrobial Agents and Chemotherapy|February 22, 2018
GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant VariantsNicole S Delino, Manabu Aoki, Hironori Hayashi, et al.Antimicrobial Agents and Chemotherapy|April 23, 2014
A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIVRavikiran S Yedidi, Harisha Garimella, Manabu Aoki, et al.Pageof 1